Hi @RaceOncology,
Very compelling presentation and it is looking bright for the next period. Very keen to participate in the raise. Wondered if you could help improve my understanding. I can see in the raise cases $7.5m to fund the P2 Cardio protection P2 trial. My limited understanding is that a P2 averages $10m-15m. I assume that working quickly to capitalise on the opportunity would be more costly than otherwise. Could you help me understand the budget and assumptions for the trial?
RAC 2021 AGM Discussion, page-103
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.71 |
Change
0.010(0.59%) |
Mkt cap ! $291.1M | |||
| Open | High | Low | Value | Volume |
| $1.74 | $1.75 | $1.70 | $226.9K | 131.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9599 | $1.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.74 | 4886 | 1 |
View Market Depth
| Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |